Greater lean-body-mass decline with tirzepatide than semaglutide in routine care revealed by body-composition digital phenotyping

By kslawinApril 13, 2026April 17th, 2026No Comments

Next PostPulmatrix picked for reverse merger with anti-aging biotech weeks after Cullgen deal collapses